BrainStorm Cell Therapeutics
BCLI
#10400
Rank
HK$51.51 M
Marketcap
HK$4.67
Share price
-1.64%
Change (1 day)
-62.02%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -HK$89.21 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$90.45 Million, an increase over its 2023 earnings that were of -HK$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$89.21 Million-1.37%
2024 -HK$90.45 Million-32.39%
2023 -HK$0.14 Billion-29.18%
2022 -HK$0.19 Billion-0.74%
2021 -HK$0.2 Billion-23.12%
2020 -HK$0.25 Billion36.8%
2019 -HK$0.19 Billion66.71%
2018 -HK$0.11 Billion181.66%
2017 -HK$38.54 Million-0.6%
2016 -HK$38.77 Million-41.31%
2015 -HK$66.05 Million-8.22%
2014 -HK$71.97 Million89.74%
2013 -HK$37.93 Million42.27%
2012 -HK$26.66 Million-12.45%
2011 -HK$30.45 Million63.04%
2010 -HK$18.68 Million35.52%
2009 -HK$13.79 Million-48.99%
2008 -HK$27.02 Million-44.39%
2007 -HK$48.59 Million
2005 -HK$25.16 Million-91.44%
2004 -HK$0.3 Billion94007.62%
2003 -HK$0.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
HK$76.92 B-86,455.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-HK$5.86 Billion 6,468.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-HK$6.16 Billion 6,805.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$14.81 B-16,731.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.16 B-280.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-HK$1.99 Billion 2,131.73%๐Ÿ‡บ๐Ÿ‡ธ USA